A recent study identified HAI-2, a cognate inhibitor of TMPRSS2, as mediating the proteolytic activity of TMPRSS2 to inhibit the invasion and metastasis of prostate cancer [31]. The gene discussed is TMPRSS2; the disease is prostate carcinoma.